| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |